Roger G Phd Stoll does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include CORTEX PHARMACEUTICALS INC/DE/, DELCATH SYSTEMS, INC., QUESTCOR PHARMACEUTICALS INC, and Chelsea Therapeutics International, Ltd..
2005 was Roger G Phd Stoll's most active year for acquiring shares with 6 total transactions. Roger G Phd Stoll's most active month to acquire stocks was the month of April. 2024 was Roger G Phd Stoll's most active year for disposing of shares, totalling 5 transactions. Roger G Phd Stoll's most active month to dispose stocks was the month of April. 2019 saw Roger G Phd Stoll paying a total of $93,000.00 for 1,650,093 shares, this is the most they've acquired in one year. In 2024 Roger G Phd Stoll cashed out on 77,824 shares for a total of $0.00, their largest year based on trade value.